What is QuaDPharma?
QuaDPharma Inc. is a player in the Pharmaceuticals industry, operating with a team of 10 to 19 employees and generating between $10 million and $25 million in revenue. The company's focus within the pharmaceutical sector positions it to leverage its recent capital infusion for expansion and development.
How much funding has QuaDPharma raised?
QuaDPharma has raised a total of $1.5M across 2 funding rounds:
Other Financing Round
$500K
Other Financing Round
$1M
Other Financing Round (2012): $500K with participation from Rand
Other Financing Round (2012): $1M led by Rand Capital SBIC , Inc. and Advantage Capital
Key Investors in QuaDPharma
Rand
RAND Corporation, founded in 1948, is a nonprofit research organization that develops solutions to public policy challenges. The company is headquartered in Santa Monica, California.
Rand Capital SBIC , Inc.
Rand Capital SBIC, Inc. is an investment firm that provides capital to businesses. Its focus areas typically include supporting small businesses and fostering economic development.
Advantage Capital
Advantage Capital Partners operates as a venture capital firm. The Company invests in cleantech, communication, energy, information technology, and life sciences industries. Advantage Capital Partners is located in New Orleans.
What's next for QuaDPharma?
The substantial enterprise-level funding indicates that QuaDPharma is likely in a growth or scaling phase. This capital injection is expected to fuel further research and development, market penetration, and potentially strategic acquisitions. The company's trajectory suggests a move towards solidifying its market position and expanding its operational footprint.
See full QuaDPharma company page
